 "Market resilience in a pill: Pharma's formula for Q3 earnings upgrades")
Pharmaceutical firms dominate the list of National Stock Exchange Nifty companies with the highest earnings upgrades after the announcement of the 2023–24 (FY24) October–December quarter (third quarter, or Q3) earnings.
On the other hand, information technology (IT), fast-moving consumer goods, and banking stocks dominate the list of downgrades.
The 2024–25 (FY25) earnings estimates for Cipla, Dr Reddy’s Laboratories, and Sun Pharmaceutical Industries have been upgraded by 8.2 per cent, 4.6 per cent, and 3.7 per cent, respectively.
HCLTech is an outlier in the IT pack with a 3.8 per cent earnings growth.
LTIMindtree, ITC, Hindustan Unilever, Axis Bank, and IndusInd Bank have seen their FY25 earnings estimates get downgraded by 3.4 per cent and 8.3 per cent.
Out of about 33 Nifty companies that have declared their earnings, eight have missed their profit estimates, nine have exceeded expectations, and 16 have met estimates.
Tata Steel, JSW Steel, and Bharat Petroleum Corporation posted the highest year-on-year growth in Q3FY24 profits, while Tech Mahindra, Wipro, and Infosys recorded a decline.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%